Fremanezumab Improved Migraine and Headache Attributed to Glioblastoma

Fremanezumab, one of the anti-calcitonin gene-related peptide monoclonal antibodies, is widely used for migraine prophylaxis. However, its efficacy for headache attributed to glioblastoma has not been reported. We herein report a 66-year-old man who had right temporoparietal glioblastoma which recur...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamura, Shin, Katsuki, Masahito, Kashiwagi, Kenta, Koh, Akihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Pain Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637455/
https://www.ncbi.nlm.nih.gov/pubmed/36381868
http://dx.doi.org/10.7759/cureus.30064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637455/
https://www.ncbi.nlm.nih.gov/pubmed/36381868
http://dx.doi.org/10.7759/cureus.30064

Ejemplares similares